The results of clinical trials on Covid-19 patients of Indian giant Patanjali Ayurveda drug 'Divya Coronil Tablet' will be announced by Yoga Guru Baba Ramdev and Acharya Balakrishna at Patanjali Yogpeeth Phase-Two today at 12 noon. Patanjali Yogpeeth has told that this research done on Corona Tablet is the result of joint efforts of Patanjali Research Institute Haridwar and National Institute of Medical Science Jaipur. The tablet is being manufactured at Divya Pharmacy and Patanjali Ayurved Limited Haridwar. During this time, teams of scientists, researchers, and doctors will also be present.
Army Chief General Narwane will visit Leh today
On June 13, Patanjali Yogpeeth General Secretary and Vice-Chancellor of Patanjali Ayurvedic University Acharya Balakrishna, in a conversation with 'Dainik Jagran', claimed that research at the Patanjali Research Institute lasted for five months and after successful testing of several rounds of research on mice, Covid-19 has been successful in preparing Ayurvedic medicine. The necessary clinical case study for this has been completed, while the clinical control trial is in its final stages. As soon as its data is available, the final analysis will be done and put into the drug market.
Corona cases increasing daily in India
According to Acharya Balakrishna, the main components of the medicine are Ashwagandha, Giloy, Tulsi, Shvasari Ras, and Molecule Oil. Their mixture and proportion have been decided according to research. He also claimed that this drug is authentic from all the major institutions, journals, etc., nationally and internationally, on the basis of its use, treatment, and effect. This research has also been published in the International Journal of Biomedicine Pharmacotherapy of America.
